Resistant Hypertension in Patients With Type-II-Diabetes Mellitus (RESIST)
|ClinicalTrials.gov Identifier: NCT01056367|
Recruitment Status : Completed
First Posted : January 26, 2010
Last Update Posted : October 12, 2011
The risk of cardiovascular disease (CVD) in patients with type-II-diabetes mellitus (type-II-DM)is more than doubled and CVD accounts for 70% of deaths in this group of patients.
Hypertension is a major risk factor for CVD in patients with type-II-DM and a major contributor cardiovascular mortality. Uncontrolled- (UH) and resistant hypertension (RH)are more common in patients with type-II-DM, why further bloodpressure (BP) control is needed.
The prevalence of UH and RH has not been examined in a consecutive Danish outpatient population with type-II-DM.
The purpose of this study is to examine the prevalence of resistant hypertension in patients with type-II-diabetes and to examine the characteristics of patients with resistant hypertension as compared to patients with controlled hypertension with regards to arterial stiffness.
|Condition or disease|
|Resistant Hypertension NIDDM|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||180 participants|
|Official Title:||Resistant Hypertension in Patients With Type-II-Diabetes Mellitus: Prevalence, Characterization and Treatment|
|Study Start Date :||June 2009|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||October 2011|
- Pulse wave velocity [ Time Frame: one year ]
- Myocardial contractility [ Time Frame: One year ]
- Pulse wave analysis [ Time Frame: One year ]
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01056367
|Department of Medical Research, Svendborg Hospital|
|Svendborg, Denmark, 5700|
|Principal Investigator:||Trine K Sønder, Cand.med.||Department of Medical Research, Svendborg Hospital|